Dianthus Therapeutics (DNTH) EBITDA Margin (QoQ) (2022 - 2025)
Dianthus Therapeutics (DNTH) EBITDA Margin (QoQ) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Dianthus Therapeutics | 3.92 Bn | 3.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 792,315.00 |
| Jun 30, 2025 | -1.53 Mn |
| Mar 31, 2025 | -35,781.00 |
| Dec 31, 2024 | -103,033.00 |
| Sep 30, 2024 | -18,477.00 |
| Jun 30, 2024 | 84,981.00 |
| Mar 31, 2024 | 79,336.00 |
| Dec 31, 2023 | -112,949.00 |
| Sep 30, 2023 | -49,025.00 |
| Jun 30, 2023 | 39,880.00 |
| Mar 31, 2023 | -70,403.00 |
| Dec 31, 2022 | -20,638.00 |